Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Compositional and Functional Alterations in Intestinal Microbiota in Patients with Psychosis or Schizophrenia: A Systematic Review and Meta-analysis
Nuala Murray, Sukainah Al Khalaf, Thomaz F. S. Bastiaanssen, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 5, pp. 1239-1255
Open Access | Times Cited: 23

Showing 23 citing articles:

Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials
Carlos Ribera, Joan Vicent Sánchez‐Ortí, Gerard Clarke, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 158, pp. 105561-105561
Open Access | Times Cited: 16
Associations of the Gut Microbiome With Treatment Resistance in Schizophrenia
Svetlina Vasileva, Yuanhao Yang, Andrea Baker, et al.
JAMA Psychiatry (2024) Vol. 81, Iss. 3, pp. 292-292
Closed Access | Times Cited: 10
Immune Dysfunction in Schizophrenia Spectrum Disorders
Shiral S. Gangadin, Anne-Sophie D. Enthoven, Nico J.M. van Beveren, et al.
Annual Review of Clinical Psychology (2024) Vol. 20, Iss. 1, pp. 229-257
Closed Access | Times Cited: 6
Dysbiosis is associated with the behavioral phenotype observed in the triple-hit Wisket rat model of schizophrenia
Szonja B Plesz, Leatitia Gabriella Adlan, Alexandra Büki, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111276-111276
Open Access
Translational perspectives of endocrine alterations in psychosis: Are we there yet?
Błażej Misiak, Javier Labad
Psychoneuroendocrinology (2025) Vol. 176, pp. 107419-107419
Closed Access
The gut microbiota-immune-brain axis: Therapeutic implications
Kenneth J. O’Riordan, Gerard Moloney, Lily Keane, et al.
Cell Reports Medicine (2025), pp. 101982-101982
Open Access
Gut microbiome and schizophrenia: insights from two-sample Mendelian randomization
Keer Zhou, Ancha Baranova, Hongbao Cao, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Altered gut microbiota and systemic immunity in Chinese patients with schizophrenia comorbid with metabolic syndrome
Zongxin Ling, Zhiyong Lan, Yiwen Cheng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Altered oral microbiota and immune dysfunction in Chinese elderly patients with schizophrenia: a cross-sectional study
Zongxin Ling, Yiwen Cheng, Xia Liu, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Gut microbial diversity moderates polygenic risk of schizophrenia
Liyuan Zhang, Xiuxia Yuan, Xue Li, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
More than just a number: the gut microbiota and brain function across the extremes of life
Nathan D. Nuzum, Clara Deady, Sarah Kittel‐Schneider, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Human-fecal microbiota transplantation in relation to gut microbiome signatures in animal models for schizophrenia: A scoping review
Raghunath Singh, Kristoffer Panganiban, Emily Au, et al.
Asian Journal of Psychiatry (2024) Vol. 102, pp. 104285-104285
Closed Access | Times Cited: 1
Probiotic Formulation for Patients With Bipolar or Schizophrenia Spectrum Disorder: A Double-Blind, Randomized Placebo-Controlled Trial
Jenny Borkent, Magdalini Ioannou, Dorien Neijzen, et al.
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 1
Insulin resistance links dysbiosis of gut microbiota with cognitive impairment in first-episode drug-naïve schizophrenia
Xiuxia Yuan, Yu Zhang, Lijuan Pang, et al.
Psychoneuroendocrinology (2024) Vol. 172, pp. 107255-107255
Closed Access | Times Cited: 1
IUPHAR Themed Review: The Gut Microbiome in Schizophrenia
Srinivas Kamath, Elysia Sokolenko, Kate Collins, et al.
Pharmacological Research (2024), pp. 107561-107561
Open Access | Times Cited: 1
Gut-brain axis system updates: Optimizing microbiome biomarkers for psychiatry and neurology
Emily G. Severance
Biomarkers in Neuropsychiatry (2024) Vol. 10, pp. 100085-100085
Open Access
In the afterglow: Immune dysfunction in schizophrenia spectrum disorders
Shiral S. Gangadin
(2024)
Open Access
Microbiota intestinal e saúde mental: Uma revisão abrangente da literatura e perspectivas terapêuticas
Luiz Henrique Cunha dos Santos, M. Silva, J. Costa, et al.
Research Society and Development (2024) Vol. 13, Iss. 4, pp. e0413445472-e0413445472
Open Access
Gut Microbiota-Brain Axis and Related Biomarkers
Margareth Borges Coutinho Gallo
(2024), pp. 95-114
Closed Access
Schizophrenia and antipsychotic medications present distinct and shared gut microbial composition: A meta-analysis
Cheng Wei-rong, Mengjie Zhao, Xinyun Zhang, et al.
Schizophrenia Research (2024) Vol. 274, pp. 257-268
Closed Access
Impact of gut microbiota on the central nervous system relevance in neurodegenerative and psychiatric diseases
Oksana Zatorska
Current Problems of Psychiatry (2024) Vol. 25, pp. 239-247
Open Access
Should We Consider Microbiota-Based Interventions as a Novel Therapeutic Strategy for Schizophrenia? A Systematic Review and Meta-Analysis
Lucas Hassib, Alexandre Kanashiro, João Francisco Cordeiro Pedrazzi, et al.
Brain Behavior & Immunity - Health (2024) Vol. 43, pp. 100923-100923
Open Access
Psychotic Illness as a Disorder of Subtle, Whole-body Maldevelopment: Challenges and Opportunities for Drug Discovery
J.L. Waddington, Xuechu Zhen
Royal Society of Chemistry eBooks (2024), pp. 19-30
Closed Access
Page 1

Scroll to top